Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data

• A.H. Varey,
• S.N. Lo,
• G.J. Williams,
• A.E. Cust,
• D. Ollila,
• R.A. Scolyer,
• J.F. Thompson

Affiliations

A.H. Varey

Melanoma Institute Australia, Sydney, Australia; University of Sydney, Faculty of Medicine and Health, Sydney, Australia; Westmead Hospital, Department of Plastic & Reconstructive Surgery, Sydney, Australia

S.N. Lo

Melanoma Institute Australia, Sydney, Australia; University of Sydney, Faculty of Medicine and Health, Sydney, Australia

G.J. Williams

Melanoma Institute Australia, Sydney, Australia

A.E. Cust

Melanoma Institute Australia, Sydney, Australia; The University of Sydney and Cancer Institute New South Wales, The Daffodil Centre, Sydney, Australia

D. Ollila

University of North Carolina, Department of Surgery, Chapel Hill, United States of America; Lineberger Comprehensive Cancer Center, Chapel Hill, United States of America

R.A. Scolyer

Melanoma Institute Australia, Sydney, Australia; University of Sydney, Faculty of Medicine and Health, Sydney, Australia; Royal Prince Alfred Hospital, Tissue Pathology and Diagnostic Oncology, Sydney, Australia

J.F. Thompson

Melanoma Institute Australia, Sydney, Australia; University of Sydney, Faculty of Medicine and Health, Sydney, Australia; Royal Prince Alfred Hospital, Melanoma and Surgical Oncology, Sydney, Australia